Oxford, UK - 19 November 2026 - Drawing on lessons from the COVID-19 pandemic, university researchers have detailed how public health agencies across the world can be better prepared for the next epidemic through effective deployment of Bluetooth contact tracing apps and related digital public health tools.
In a White Paper published today by the Oxford Martin School Programme on Digital Pandemic Preparedness, academics describe how digital contact tracing tools offered significant potential in the global battle against COVID-19, but that lack of preparation and investment led to delayed deployments and missed opportunities. Whilst Bluetooth-based contract tracing apps were rapidly developed, issues around public trust, privacy, integration, equity, and knowledge sharing took longer to solve and limited their impact.
Professor Christophe Fraser is Moh Family Foundation Professor of Infectious Disease Epidemiology at the Pandemic Sciences Institute, University of Oxford, and leads the Programme. He said: “At the start of the COVID-19 pandemic, many countries discovered that they were under-prepared and were forced into improvised responses. In particular, countries with less recent experience of large-scale infectious disease emergencies had typically under-invested in working out how to act early and quickly to interrupt transmission, and how to enhance traditional, proven public health measures like contact tracing to use the latest technology and keep pace with modern life.
"We are calling on Governments and public health agencies across the globe to ensure that digital tools such as Bluetooth contact tracing apps are ready to support outbreak response from the first days of the next pandemic. Digital tools can make a substantial contribution to epidemic control, but most countries remain unprepared to deploy and govern these tools effectively. Whilst refining the technology is a core part of the solution, there needs to be greater focus on building ethical, trusted and interoperable digital public-health infrastructure in advance of the next outbreak.”
The White Paper describes how digital contact tracing apps were deployed in at least 90 countries during COVID-19, with an estimated 600 million users worldwide. However, there were vast differences in how the apps were received. In some countries there was low uptake and the apps had no measurable impact on the epidemic. Other countries saw record-breaking uptake, strong engagement, and correspondingly large epidemiological impacts.
Professor Michael Parker, Director of the Ethox Centre at Oxford Population Health, said: “It is clear that well-designed digital tools have the potential to make a significant contribution to pandemic preparedness and response. That is, to saving lives, reducing suffering, and enabling more informed, less intrusive, public health interventions. However, these important benefits will only be achievable if the development and deployment of digital tools is equitable and deserving of well-founded public trust and confidence.
"Evidence suggests that the uptake of digital tools depends on perceived trustworthiness of relevant institutions and legitimacy of decision-making processes. People’s willingness to comply with such interventions, such as self-isolating or taking a test on the recommendation of an app notification, depended on trust but also on practical considerations: for many individuals, the economic and social costs of self-isolation were prohibitive. Together these findings suggest the importance of embedding research on ethics and social and behavioural science into pandemic preparedness planning and policy development.”
The paper discusses the interdependence of elements of the public health ‘toolkit’, particularly the natural dependence of contact tracing on diagnostic testing. A key benefit of digital contact tracing is that it can easily scale up to meet population demand, whereas laboratory tests have natural limits on daily capacity and turnaround times. Symptom-based alerts and rapid home tests can play a role in supporting the case-finding system, and a robust public health response would be adaptable to rapidly changing intervention options and epidemic dynamics.
Delays to app deployments, which limited their ability to support the pre-vaccine phase of the pandemic, are also highlighted by the paper as an area for improvement.
Dr Michelle Kendall, Senior Researcher in Infectious Disease Epidemiology at the Pandemic Sciences Institute, and Research Fellow and Impact Lead on the Oxford Martin School Programme for Digital Pandemic Preparedness, led the writing of the paper. She said: “Where available, vaccines and treatments are the most effective public health measures for sustained disease control. However, they take time and money to develop, manufacture, transport, test, license and administer.
“In countries where digital contact tracing apps were effective, they had a considerable impact on reducing transmissions, hospitalisations and deaths. However, many were only deployed after the first epidemic wave, after key therapeutic interventions had been discovered, and only shortly before vaccine roll-outs began. The digital tools were not available when they could have had maximal impact.
“With some ‘peacetime’ investment, digital contact tracing apps could be ready to play a key, low-cost role in mitigating infectious disease transmission from Day 1 of a future outbreak.”
Preparing for the next pandemic
The Oxford Martin School team held an international workshop in September which brought together interdisciplinary experts to reflect on lessons from COVID-19 and to discern the current research and investment gaps which are limiting our digital pandemic preparedness. This community of researchers are now calling for public health agencies to invest in digital public health technology before the next infectious disease emergency, proposing three key requirements:
- Day 1 readiness. The majority of the design work and testing of digital tools should take place between emergencies rather than in the midst of an outbreak, with expert input from behavioural science, ethics, technology, public health and epidemiology, and engagement with relevant publics, particularly communities at risk of exclusion or disproportionate harm. Platform approaches which can be quickly tailored to the pathogen and setting would enable gaps and solutions to be identified rapidly in a crisis, and peacetime use cases would keep the technology warm and ready to scale up in an emergency.
- Public health integration. Digital tools need to be integrated by public health agencies into their wider ‘toolkit’ of outbreak response, and regularly updated in line with the changing dynamics of an outbreak and developments in our understanding of symptoms and risk factors.
- Autonomy-preserving data and analytics. Digital tools should collect data in a way that preserves the privacy of users and is acceptable to the public, whilst providing public health agencies with sufficient and relevant data. Processes for the collection, storage, analysis and reporting of data should be confirmed now, ahead of the next outbreak.
The White Paper titled Digital pandemic preparedness: key principles and requirements, building on lessons from COVID-19 is available to download now.
Notes to Editors
- The research was funded by the Oxford Martin School Programme on Digital Pandemic Preparedness.
- For enquiries and media interviews, please contact communications.psi@ndm.ox.ac.uk
About the University of Oxford
Oxford University has been placed number 1 in the Times Higher Education World University Rankings for the eleventh year running, and number 3 in the QS World Rankings 2024. At the heart of this success are the twin-pillars of our ground-breaking research and innovation and our distinctive educational offer.
Oxford is world-famous for research and teaching excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research alongside our personalised approach to teaching sparks imaginative and inventive insights and solutions.
Through its research commercialisation arm, Oxford University Innovation, Oxford is the highest university patent filer in the UK and is ranked first in the UK for university spinouts, having created more than 300 new companies since 1988. Over a third of these companies have been created in the past five years. The university is a catalyst for prosperity in Oxfordshire and the United Kingdom, contributing around £16.9 billion to the UK economy in 2021/22, and supports more than 90,400 full time jobs.
About the Pandemic Sciences Institute
The Pandemic Sciences Institute (PSI) is an interdisciplinary research institute at the University of Oxford dedicated to confronting the challenge of epidemic and pandemic infectious diseases. We work with academia, industry and public health organisations across the world to create science-led innovations, accelerate understanding, and develop new diagnostics, treatments, vaccines and disease control tools.
Launched in 2022, PSI brings together researchers from across all four academic divisions of the University of Oxford: Medical Sciences; Mathematical, Physical and Life Sciences; Social Sciences; and Humanities.
We have 200 core PSI research and support staff, with an additional 400 or more affiliated staff and students, based at institutes and centres across the University. PSI is hosted by the Nuffield Department of Medicine.
Acknowledgements
This research was funded by the Oxford Martin School Programme on Digital Pandemic Preparedness. Christl Donnelly is funded by the National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections (NIHR207393). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Michael Parker is supported by the Wellcome Trust (320225) and the Moh Family Foundation. Ciro Cattuto is supported by the Lagrange Project of the ISI Foundation funded by CRT Foundation. Vittoria Colizza is supported by the EU Horizon Europe program (ESCAPE, 101095619) and by the ANRS Maladies Infectieuses Émergentes and France 2030 (PreViX, ANRS-24-PEPRMIE-0003).
Method of Research
Commentary/editorial
Subject of Research
People